FeF® Strong Cetrimide Solution 40% BP Pharma with Ethanol

Also known as Cetrimide, Cetrimoni Bromidum and Tetradecyl Trimethyl Ammonium Bromide (TTAB), FeF® Strong Cetrimide Solution 40% BP Pharma with Ethanol FeF® (CAS No. 1119-97-7) consists of approximately 20% dodecyl trimethyl ammonium bromide, approximately 70% trimethyl tetradecyl ammonium bromide and around 10% hexadecyl trimethyl ammonium bromide.

Manufactured in accordance with current good manufacturing practice (cGMP) guideline ICH Q7 for Active Pharmaceutical Ingredients, FeF® is analysed according to meet current British Pharmacopoeia (BP) guidelines.

Packaging sizes:

  • Item number: 7800024, 200kg drum

Documentation and services

Novo Nordisk Pharmatech offers a wide range of documentation, including:

  • European drug master file (ASMF)
  • Good manufacturing practice (GMP) certificate
    Certificate of Analysis (current version of Pharmacopoeia)
  • Datasheets
  • Customer audits
  • Stability results
  • Declarations and statements such as transmissible spongiform encephalopathy (TSE) / bovine spongiform encephalopathy (BSE) statements, residual solvents, genetically modified organism (GMO), allergens and animal testing
  • Reach
  • Change notification statement
  • Pre-filled supplier questionnaire
  • Impurity profile
  • Description of the manufacturing process
  • Process flowchart
  • Packaging details
  • Quality agreements

More About This Company